Matthew Guille

Matthew Guille

Auto-generated profile, based on publicly available information

Matthew Guille

University of Portsmouth

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AKAndrew J. King
Andrew J. King
SCSimon M. Cragg
Simon M. Cragg
YLYi Li
Yi Li
JDJo Dymond
Jo Dymond
MGMatthew J. Guille
Matthew J. Guille
SMSimon J. McQueen-Mason
Simon J. McQueen-Mason
The digestion of lignocellulose is attracting attention both in terms of basic research into its metabolism by microorganisms and animals, and also as a means of converting plant biomass into biofuels. Limnoriid wood borers are unusual because, unlike other wood-feeding animals, they do not rely on symbiotic microbes to help digest lignocellulose. The absence of microbes in the digestive tract suggests that limnoriid wood borers produce all the enzymes necessary for lignocellulose digestion themselves. In this study we report that analysis of ESTs from the digestive system of Limnoria quadripunctata reveals a transcriptome dominated by glycosyl hydrolase genes. Indeed, > 20% of all ESTs represent genes encoding putative cellulases, including glycosyl hydrolase family 7 (GH7) cellobiohydrolases. These have not previously been reported in animal genomes, but are key digestive enzymes produced by wood-degrading fungi and symbiotic protists in termite guts. We propose that limnoriid GH7 genes are important for the efficient digestion of lignocellulose in the absence of gut microbes. Hemocyanin transcripts were highly abundant in the hepatopancreas transcriptome. Based on recent studies indicating that these proteins may function as phenoloxidases in isopods, we discuss a possible role for hemocyanins in lignin decomposition.

1 March 2020 in The American Journal of Human Genetics
Verified
Journal Article
Open access
SBSónia Barbosa
Sónia Barbosa
SGStephanie Greville-Heygate
Stephanie Greville-Heygate
MBMaxime Bonnet
Maxime Bonnet
AGAnnie Godwin
Annie Godwin
CFChristine Fagotto-Kaufmann
Christine Fagotto-Kaufmann
DBDiana Baralle
Diana Baralle
The Rho-guanine nucleotide exchange factor (RhoGEF) TRIO acts as a key regulator of neuronal migration, axonal outgrowth, axon guidance, and synaptogenesis by activating the GTPase RAC1 and modulating actin cytoskeleton remodeling. Pathogenic variants in TRIO are associated with neurodevelopmental diseases, including intellectual disability (ID) and autism spectrum disorders (ASD). Here, we report the largest international cohort of 24 individuals with confirmed pathogenic missense or nonsense variants in TRIO. The nonsense mutations are spread along the TRIO sequence, and affected individuals show variable neurodevelopmental phenotypes. In contrast, missense variants cluster into two mutational hotspots in the TRIO sequence, one in the seventh spectrin repeat and one in the RAC1-activating GEFD1. Although all individuals in this cohort present with developmental delay and a neuro-behavioral phenotype, individuals with a pathogenic variant in the seventh spectrin repeat have a more severe ID associated with macrocephaly than do most individuals with GEFD1 variants, who display milder ID and microcephaly. Functional studies show that the spectrin and GEFD1 variants cause a TRIO-mediated hyper- or hypo-activation of RAC1, respectively, and we observe a striking correlation between RAC1 activation levels and the head size of the affected individuals. In addition, truncations in TRIO GEFD1 in the vertebrate model X. tropicalis induce defects that are concordant with the human phenotype. This work demonstrates distinct clinical and molecular disorders clustering in the GEFD1 and seventh spectrin repeat domains and highlights the importance of tight control of TRIO-RAC1 signaling in neuronal development.

15 January 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CGChris Gove
Chris Gove
MWMaggie Walmsley
Maggie Walmsley
SNSarbjit Nijjar
Sarbjit Nijjar
DBDavid Bertwistle
David Bertwistle
MGMatthew Guille
Matthew Guille
RPRoger Patient
Roger Patient
Xenopus GATA‐6 transcripts are first detected at the beginning of gastrulation in the mesoderm, and subsequent domains of expression include the field of cells shown to have heart‐forming potential. In this region, GATA‐6 expression continues only in those cells that go on to form the heart; however, a decrease occurs prior to terminal differentiation. Artificial elevation of GATA‐6, but not GATA‐1, prevents expression of both cardiac actin and heart‐specific myosin light chain. This effect is heart‐specific because cardiac actin expression is unaffected in somites. Expression of the earlier marker XNkx‐2.5 was unaffected and morphological development of the heart was initiated independently of the establishment of the contractile machinery. We conclude that a reduction in the level of GATA‐6 is important for the progression of the cardiomyogenic differentiation programme and that GATA‐6 may act to maintain heart cells in the precursor state. At later stages, when the elevated GATA‐6 levels had decayed, differentiation ensued but the number of cells contributing to the myocardium had increased, suggesting either that the blocked cells had proliferated or that additional cells had been recruited.

30 January 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGStephen J. Gregson
Stephen J. Gregson
PHPhilip W. Howard
Philip W. Howard
DGDarren R. Gullick
Darren R. Gullick
AHAnzu Hamaguchi
Anzu Hamaguchi
KCKathryn E. Corcoran
Kathryn E. Corcoran
DTDavid E. Thurston
David E. Thurston

22 June 2017 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
SWSyed F. Hassnain Waqas
Syed F. Hassnain Waqas
ANAnna Noble
Anna Noble
AHAnh C. Hoang
Anh C. Hoang
GAGrace Ampem
Grace Ampem
MPManuela Popp
Manuela Popp
Tamás RöszerTamás Röszer
Tamás Röszer
ATMs have a metabolic impact in mammals as they contribute to metabolically harmful AT inflammation. The control of the ATM number may have therapeutic potential; however, information on ATM ontogeny is scarce. Whereas it is thought that ATMs develop from circulating monocytes, various tissue-resident Mϕs are capable of self-renewal and develop from BM-independent progenitors without a monocyte intermediate. Here, we show that amphibian AT contains self-renewing ATMs that populate the AT before the establishment of BM hematopoiesis. Xenopus ATMs develop from progenitors of aVBI. In the mouse, a significant amount of ATM develops from the yolk sac, the mammalian equivalent of aVBI. In summary, this study provides evidence for a prenatal origin of ATMs and shows that the study of amphibian ATMs can enhance the understanding of the role of the prenatal environment in ATM development.

15 December 2011 in Development
Verified
Journal Article
Open access
PDF file
NLNick R. Love
Nick R. Love
RTRaphael Thuret
Raphael Thuret
YCYaoyao Chen
Yaoyao Chen
SIShoko Ishibashi
Shoko Ishibashi
NSNitin Sabherwal
Nitin Sabherwal
EAEnrique Amaya
Enrique Amaya
As studies aim increasingly to understand key, evolutionarily conserved properties of biological systems, the ability to move transgenesis experiments efficiently between organisms becomes essential. DNA constructions used in transgenesis usually contain four elements, including sequences that facilitate transgene genome integration, a selectable marker and promoter elements driving a coding gene. Linking these four elements in a DNA construction, however, can be a rate-limiting step in the design and creation of transgenic organisms. In order to expedite the construction process and to facilitate cross-species collaborations, we have incorporated the four common elements of transgenesis into a modular, recombination-based cloning system called pTransgenesis. Within this framework, we created a library of useful coding sequences, such as various fluorescent protein, Gal4, Cre-recombinase and dominant-negative receptor constructs, which are designed to be coupled to modular, species-compatible selectable markers, promoters and transgenesis facilitation sequences. Using pTransgenesis in Xenopus, we demonstrate Gal4-UAS binary expression, Cre-loxP-mediated fate-mapping and the establishment of novel, tissue-specific transgenic lines. Importantly, we show that the pTransgenesis resource is also compatible with transgenesis in Drosophila, zebrafish and mammalian cell models. Thus, the pTransgenesis resource fosters a cross-model standardization of commonly used transgenesis elements, streamlines DNA construct creation and facilitates collaboration between researchers working on different model organisms.